CVS Health, Inc. (CVS) company — Signify Health — recently launched a new heart arrhythmia test. The addition of new test expands the company’s Diagnostic and Preventive Services offering.It is worth mentioning that Atrial fibrillation (AFib) is on the rise among seniors in the United States. Early detection in the home can help mitigate symptoms and more severe complications.The latest launch will bolster CVS Health’s Services segment.More on the NewsPeople who have undiagnosed heart arrhythmias suffer fro ...

ToplineCVS and Walgreens will begin selling the abortion pill mifepristone at pharmacies across select states in the coming weeks, as the Supreme Court gears up to hear oral arguments about the drug at the end of the month.The chains will sell the drug at pharmacies across several states. Corbis via Getty Images Key FactsThe pharmacy chains received certification from the Food and Drug Administration to dispense the pill, according to the New York Times, which originally reported the news. CVS said it is w ...

CVS and Walgreens said they will start dispensing the abortion pill mifepristone at pharmacies in a select number of states later this month.Officials at the two largest pharmacy chains in the US said in interviews Friday that they had received certification to dispense mifepristone under guidelines that the Food and Drug Administration issued last year, The New York Times earlier reported.The chains initially plan to make the medication available at a select number of Walgreens pharmacies in New York, Penn ...

A container holding boxes of Mifepristone, the first medication in a medical abortion, are prepared for patients at Alamo Women's Clinic in Carbondale, Illinois, April 20, 2023.CVS and Walgreens will start selling the abortion pill mifepristone this month at certain pharmacy locations in states where it is legal to do so, spokespeople for the companies told CNBC on Friday. CVS and Walgreens received certification from the Food and Drug Administration to dispense the commonly used pill at their retail pharma ...

While telehealth stocks, once stars of the pandemic era, have seen a recent dip in investor interest, savvy investors recognize the sector’s bright future. Moreover, according to TalkSpace (NASDAQ:TALK) CEO Jon Cohen, it could be argued that the pandemic catapulted telehealth forward by a decade, ushering in a new era of at-home primary and specialty care demanding investor attention.Furthermore, the consensus over the health of the U.S. economy is largely positive, which bodes well for relatively risky pla ...

CVS Health (CVS) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.Shares of this drugstore chain and pharmacy benefits manager have returned +5.8% over the past month versus the Zacks S&P 500 composite's +4.7% change. The Zacks Retail - Pharmacies and Drug Stores industry, to which CVS Health belongs, has gained 1.5% over this period. Now the key question is: Where could the stock be he ...

The investments are one of many initiatives ranging from retail to workforce and philanthropy that exemplify the company's longstanding commitment to the people of Hawai'iWOONSOCKET, R.I., Feb. 21, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced its contribution of nearly $35 million in equity investments towards the creation of two new affordable housing developments in Hawai'i. Located in Lahaina, Maui and Kapolei, Oahu, the communities will also offer residents supportive social and educatio ...

WOONSOCKET, R.I., Feb. 21, 2024 /PRNewswire/ -- CVS Health (NYSE: CVS) today announced that Executive Vice President and Chief Financial Officer Tom Cowhey will participate in a fireside chat with investors at the 45nd Annual Raymond James Institutional Investors Conference on March 5, 2024, at approximately 9:50 a.m. eastern time.An audio webcast of the event will be broadcast simultaneously on the Investor Relations portion of the CVS Health website at investors.cvshealth.com where it will be archived for ...

CVS Health Corporation (CVS) is well-poised for growth, backed by its consistently strong sales momentum across all three operating segments. The acquisition of Oak Street Health advances its care delivery strategy for consumers, which is likely to boost future growth. However, stiff competition and poor macroeconomic conditions are a concern.In the past year, this Zacks Rank #3 (Hold) stock has declined 10.3% compared with the industry’s 17.6% fall and the S&P 500’s 22.1% rise.The pharmacy innovation compa ...

CVS Health’s (CVS) restructuring plan, intended to streamline and simplify the organization, looks impressive. However, reimbursement pressure remains a concern. The stock currently carries a Zacks Rank #3 (Hold).CVS Health is committed to increasing investments in fast-growing spaces like enterprise data platforms, cloud capabilities and digital products to offer innovative solutions through mobile and web channels. The company is investing in emerging technology capabilities such as voice, artificial inte ...